NCT06872541View on ClinicalTrials.gov

Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

October 20, 2026

Study Completion Date

October 20, 2027

Conditions
Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma
Interventions
DRUG

Clopidogrel

Clopidogrel 75 mg uma vez ao dia durante 14 dias

Trial Locations (1)

Unknown

Heart Institute (InCor) / University of São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT06872541 - Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas | Biotech Hunter | Biotech Hunter